Literature DB >> 12352006

Animal models of immune-mediated neuropathies.

Mathias Mäurer1, Ralf Gold.   

Abstract

PURPOSE OF REVIEW: This article gives an overview on animal models for immune-mediated demyelinating disorders of the peripheral nervous system. As insight into human disease is mainly based on biopsy material and ex-vivo analysis, an understanding of the pathogenetic mechanism of these complex and heterogeneous disorders is mainly based on animal models. RECENT
FINDINGS: Besides experimental autoimmune neuritis in rats, recent efforts to establish this model in mice are discussed. In addition, models for spontaneous autoimmune neuropathies and secondary immune reactions in degenerative disorders of the peripheral nervous system are reviewed.
SUMMARY: Recently described animal models offer the possibility to analyse the complex interaction of genetic and immunological factors. The entire panel of animal models for immune-mediated disorders of the peripheral nervous system provides a rational basis for studying the mechanisms of pathogenesis and new immunotherapeutic strategies for human autoimmune demyelinating neuropathies.

Entities:  

Mesh:

Year:  2002        PMID: 12352006     DOI: 10.1097/00019052-200210000-00013

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  11 in total

Review 1.  [Autoimmune neuropathies--current aspects of immunopathologic diagnostics and therapy].

Authors:  R Gold; A Bayas; K V Toyka
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

Review 2.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

3.  Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.

Authors:  Patricia A Nelson; Mojgan Khodadoust; Thomas Prodhomme; Collin Spencer; Juan Carlos Patarroyo; Michel Varrin-Doyer; Joseph D Ho; Robert M Stroud; Scott S Zamvil
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 4.  [The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies].

Authors:  M Stangel; H-P Hartung; R Gold; B C Kieseier
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

5.  Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules.

Authors:  Gerd Meyer zu Hörste; Anne K Mausberg; Johanna I Müller; Helmar C Lehmann; Stefan Löber; Peter Gmeiner; Hans-Peter Hartung; Olaf Stüve; Carsten Korth; Bernd C Kieseier
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

6.  A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.

Authors:  Mu Yang; Anthony Rainone; Xiang Qun Shi; Sylvie Fournier; Ji Zhang
Journal:  Acta Neuropathol Commun       Date:  2014-01-08       Impact factor: 7.801

Review 7.  Novel pathomechanisms in inflammatory neuropathies.

Authors:  David Schafflick; Bernd C Kieseier; Heinz Wiendl; Gerd Meyer Zu Horste
Journal:  J Neuroinflammation       Date:  2017-11-28       Impact factor: 8.322

8.  A Brain-Derived Neurotrophic Factor-Based p75NTR Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and Demyelination.

Authors:  David G Gonsalvez; Giang Tran; Jessica L Fletcher; Richard A Hughes; Suzanne Hodgkinson; Rhiannon J Wood; Sang Won Yoo; Mithraka De Silva; Wong W Agnes; Catriona McLean; Paul Kennedy; Trevor J Kilpatrick; Simon S Murray; Junhua Xiao
Journal:  eNeuro       Date:  2017-07-04

9.  Expression of RhoA by inflammatory macrophages and T cells in rat experimental autoimmune neuritis.

Authors:  Zhiren Zhang; Uwe Fauser; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2007 Jan-Feb       Impact factor: 5.310

10.  FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies.

Authors:  Gerd Meyer zu Hörste; Steffen Cordes; Anne K Mausberg; Alla L Zozulya; Carsten Wessig; Tim Sparwasser; Christian Mathys; Heinz Wiendl; Hans-Peter Hartung; Bernd C Kieseier
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.